International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
Santa Cruz Institute for Particle Physics Santa Cruz Institute for Particle Physics The Santa Cruz Institute for Particle Physics (SCIPP) is an organized research unit within the University of California system. SCIPP's scientific and technical staff are and have been involved in several cutting edge research projects for more than 25 years. The primary focus is experimental and theoretical particle physics and particle astrophysics, including the development of technologies needed to advance that research. SCIPP is also pursuing the application of those technologies to other scientific fields such as neuroscience and biomedicine. The Institute is recognized as a leader in the development of custom readout electronics